Quinagolide

Norprolac 25 Microgramos y 50 Microgramos Comprimidos

0,0273 mg + 0,0546 mg comprimidoSpainWithdrawnAuthorised 30 Jun 1996

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
NORPROLAC 25 MICROGRAMOS Y 50 MICROGRAMOS COMPRIMIDOS , (25 mg) 3 comp + (50 mg) 3 comp

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Quinagolide

Norprolac 25 Microgramos y 50 Microgramos Comprimidos

0,0273 mg + 0,0546 mg comprimidoSpainWithdrawnAuthorised 30 Jun 1996

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
NORPROLAC 25 MICROGRAMOS Y 50 MICROGRAMOS COMPRIMIDOS , (25 mg) 3 comp + (50 mg) 3 comp

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Quinagolide
Strength: 0,0273 mg + 0,0546 mg
Dosage form: comprimido
Route: vía oral
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 30 Jun 1996
Registration: 60631
Marketing authorisation holder: Ferring S.A.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica